4//SEC Filing
Paya Carlos V 4
Accession 0001649094-24-000122
CIK 0001649094other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 4:14 PM ET
Size
11.6 KB
Accession
0001649094-24-000122
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Paya Carlos V
Director
Transactions
- Gift
Common Stock
2024-12-06−2,500→ 1,550 total - Award
Stock Option (right to buy)
2024-12-09+7,250→ 7,250 total(indirect: By Trust)Exercise: $72.51Exp: 2034-06-05→ Common Stock (7,250 underlying) - Award
Common Stock
2024-12-06+2,500→ 5,625 total(indirect: By Trust) - Gift
Stock Option (right to buy)
2024-12-09−7,250→ 0 totalExercise: $72.51Exp: 2034-06-05→ Common Stock (7,250 underlying)
Footnotes (4)
- [F1]The reported transactions involve the Reporting Person's transfer of certain securities to a trust for the sole benefit of the Reporting Person.
- [F2]As previously disclosed in Reporting Person's Form 4 filed on June 10, 2024, this represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.
- [F3]Shares are held directly by a trust for the sole benefit of the Reporting Person.
- [F4]The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.
Documents
Issuer
Vaxcyte, Inc.
CIK 0001649094
Entity typeother
Related Parties
1- filerCIK 0001606244
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 4:14 PM ET
- Size
- 11.6 KB